Activist investor Oasis buys 5% stake in scandal-hit Kobayashi Pharma
OSAKA -- Hong Kong-based activist investor Oasis Management has built a 5.2% stake in troubled Japanese drugmaker Kobayashi Pharmaceutical, according to securities filings submitted Wednesday.